With economic uncertainty ruling large portions of the landscape right now, it will come as no surprise that investors are looking for stocks ...
Truist analyst Bill Chappell upgraded Scotts Miracle-Gro (SMG) to Buy from Hold with an unchanged price target of $70. The U.S. lawn and garden ...
Torfinnur Jákupsson (top left), Benjamin McGrath (bottom left), a series shooting in the Faroe Islands, where 'Reyna' is set GRO Studios, Three Rivers Fiction EXCLUSIVE: The Faroe Islands’ GRÓ ...
In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant.
GRO Biosciences, a small but ambitious biotech startup attempting to create novel protein drugs from genetically modified bacteria, has cut most of its staff af ...
Expanding on the success of the MLB Debut Patch, Topps, Major League Baseball and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
CAMBRIDGE, Mass., March 11, 2025--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback